V114-005 A Phase l-ll, randomized, Double-Blind, Study to Evaluate the safety, Tolerability, and Immunogenicity of Different formulations of V114 in Healthy Adults and Infants

Project: Research project

Project Details

StatusFinished
Effective start/end date8/18/15 → 8/17/18

Funding

  • Merck Sharp and Cohme Corporation ( Award # ): $11,250.00